Evaluation of 600 mg/m2 cytarabine arabinoside as treatment for meningoencephalomyelitis of unknown origin in 43 dogs

Six hundred mg/m2 CA was well tolerated and effectively controlled disease in most dogs with MUO. Response rate was lower for dogs with spinal cord MUO or presumptive NME.